For patients who won't inject, for patients in regions where the cold chain for injectables is unreliable, and for first-time GLP-1 users who want a lower-commitment starting point, it's an appealing choice
The reconstitution process for retatrutide is more sensitive to technique than semaglutide, which is why some researchers experience degradation after reconstitution
Because retatrutide significantly reduces appetite and slows gastric emptying, individuals participating in clinical trials may consume considerably less food than usual
prescribed semaglutide who did not have a diagnosis of type 2 diabetes rapidly increased from 11.4% in 2020 to 41.7% in 2023 [Figure 2]
Since Retatrutide is not approved for general consumer use in the UK, it is illegal to sell, supply, or use it for non-research purposes
This compensation does not influence the accuracy or integrity of this content